ReviewSeminars in immunology2009
Barrier immunity and IL-17.
Review in Seminars in immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Deeper insight into the role of IL-17 in the relationship beween hypertension and intestinal physiology.Journal of inflammation (London, England) · 2022Review
- Identification of Corosolic and Oleanolic Acids as Molecules Antagonizing the Human RORγT Nuclear Receptor Using the Calculated Fingerprints of the Molecular Similarity.International journal of molecular sciences · 2022Article
- From IL-17 to IFN-γ in inflammatory skin disorders: Is transdifferentiation a potential treatment target?Frontiers in immunology · 2022Review
- The Deletion of IL-17A EnhancesJournal of inflammation research · 2022Article
- Preparation of a novel monoclonal antibody against caprine interleukin-17A and its applications in immunofluorescence and immunohistochemistry assays.BMC biotechnology · 2019Article
- Immune Response to MucosalFrontiers in immunology · 2019Review
- Patient Susceptibility to Candidiasis-A Potential for Adjunctive Immunotherapy.Journal of fungi (Basel, Switzerland) · 2018Review
- Number 2 Feibi Recipe Reduces PM2.5-Induced Lung Injury in Rats.Evidence-based complementary and alternative medicine : eCAM · 2018Article
- Article
- An Organismal Model for Gene Regulatory Networks in the Gut-Associated Immune Response.Frontiers in immunology · 2017Review
- Overexpression and Potential Regulatory Role of IL-17F in Pathogenesis of Chronic Periodontitis.Inflammation · 2015Article
- Preclinical evaluation of HIV eradication strategies in the simian immunodeficiency virus-infected rhesus macaque: a pilot study testing inhibition of indoleamine 2,3-dioxygenase.AIDS research and human retroviruses · 2013Article
- Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets.Immunity · 2013Article
- CIKS/Act1-mediated signaling by IL-17 cytokines in context: implications for how a CIKS gene variant may predispose to psoriasis.Journal of immunology (Baltimore, Md. : 1950) · 2012Article
- Host responses to Candida albicans: Th17 cells and mucosal candidiasis.Microbes and infection · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
CD4+ T(H)17 cells display a featured role in barrier immunity. This effector population of T cells is important for clearance of microorganisms but can also promote autoimmunity at barrier sites. Recent work has indicated that these effector cells share a pathway with CD4+ regulatory T cells (T(R) cells) that also have a critical function in barrier protection and immune regulation. The development and function of T(H)17 cells, and their relationship with T(R) cells are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.